Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Drug Development and Delivery ; 23(3):41-45, 2023.
Article in English | EMBASE | ID: covidwho-20241504
2.
BioPharm International ; 36(5):3, 2023.
Article in English | EMBASE | ID: covidwho-20236726
3.
Medico-Legal Update ; 23(2):4-9, 2023.
Article in English | EMBASE | ID: covidwho-20232505

ABSTRACT

The purpose of research was to study practices, barriers, and solutions of Phetchabun health massage establishments under COVID-19 situation. Non-participant observation, informal interview, in-depth interview, and participation observation were carried out respectively. Purposive sampling was used with 15 health consumer protection officers in charge;11 district level, 2 provincial level, 2 regional level as well as each representative of 11 districts. Results after implementation of "Preparation Guidelines for Health Spa, Health Massage, and Beauty Massage to Promote Health Tourism During COVID-19 Pandemic" were categorized into two sections. Firstly, the practices, barriers, and solutions of government officer performances included preparation for reopening, monitoring of the provider practices, and performance report. Secondly, the provider operations consisted of doing "Self-Assessment of Health Establishment", logging-in webpage before reopening, and practices for clients included screening and report of patients under investigation, establishment monitor, service, and establishment cleaning. In summary, the preparation guidelines were purposed to reopen their business with numerous contents and messages written by official language, it caused establishment providers and practitioners difficultly understood when applying. LINE Application and making calls were easy and accessible methods for their communication to reach current data and to ensure exact information. Various encouragements and having compliments were also considerable to form trust and confidence among them, they also raised their proud.Copyright © 2023, World Informations Syndicate. All rights reserved.

4.
Indian Journal of Pharmaceutical Education and Research ; 57(2):603-611, 2023.
Article in English | EMBASE | ID: covidwho-2295961

ABSTRACT

Background: Pharmaceutical businesses had enormous difficulties in product distribution during COVID-19, and the solution to this perpetual issue is a resilient supply chain. Aim(s): The study aims to understand the vulnerabilities to which it subjected the pharmaceutical product distribution supply chains during the COVID-19 pandemic and further develop an adaptive model through which the pharmaceutical product supply chain can enhance its resilience capabilities. Material(s) and Method(s): The conceptual model is developed for the supply chain of pharmaceutical companies based on the literature survey, and then the conceptual model is explored through factor analysis. Researchers have developed a validated model after a statistical analysis using Cronbach's alpha. Subjective analysis has concluded that the pharmaceutical supply chain's resilience is driven by factors such as "trade cost," which comprises transport cost, business practices, and raw material sourcing cost;"shock propagation," which comprises country-specific shocks, production shocks, and policy changes;and "technological infrastructure bottleneck," which relates to the availability of cold chain storage warehouses and refrigerated transport vehicle facilities. Result(s): An empirical model pertaining to supply chain resilience may be further studied with different geographies, like Pune, Hyderabad, and Delhi NCR, for the purpose of generalizing the study. Conclusion(s): The identified major factors were trade cost, shock propagation, and technological infrastructure bottlenecks. The sensitivity of the issue under investigation required a personal touch to the survey, as the COVID-19 pandemic had left these respondents emotionally vulnerable. As COVID-19 is the recent catastrophe that has hit humanity, it has made the pharmaceutical product distribution channel vulnerable during the pandemic. This difficult time of pandemic has really tested the pharmaceutical products' supply chain capabilities as well.Copyright © 2023, Association of Pharmaceutical Teachers of India. All rights reserved.

5.
New Zealand Medical Journal ; 136(1568):84-97, 2023.
Article in English | EMBASE | ID: covidwho-2271170

ABSTRACT

Aim: This study investigates the digital transition initiated by the onset of the COVID-19 pandemic and the factors that enabled the digitalisation of general practices (GPs) in New Zealand. method: Using a multiple case study design, we conducted 86 in-depth interviews with staff from 16 GP centres in New Zealand. Result(s): The critical enablers of digital transition in response to the pandemic were support from the community, agility and adaptability of GP medical centres and the ability to pragmatically create external operational processes to ensure business continuity and to meet patient expectations. Major barriers to digitalisation at the early stage of the COVID-19 pandemic (28 February to 30 August 2020) included lack of organisational leadership, financial support availability, systems management collaboration, and patient and staff knowledge and preferences. Digitalisation was characterised by the GP centre's ability to provide telehealth services using existing systems and technology, embracing e-prescription, e-referrals, e-lab and video-only consults. conclusion: The decision to adopt digitalisation had a significant impact on GP centres, disrupting the norm but also allowing continued access to health services to patients who were the most vulnerable during the pandemic. The pandemic forced GP medical centres to change to digitalisation and led to significant changes in GP medical centres' business models. However, it remains to be seen how the rapid change effected at this time correlates with patient satisfaction and how the digitalisation capabilities that have been built impact on future primary care services. This study suggests that changes brought about by COVID-19 may pave the way to an expansion of GP telehealth services, which has the potential to permanently change the primary care landscape.Copyright © 2023 New Zealand Medical Association. All rights reserved.

6.
Journal of Pharmaceutical Negative Results ; 13:2961-2965, 2022.
Article in English | EMBASE | ID: covidwho-2280527

ABSTRACT

In practically all economies, the COVID-19 pandemic has triggered an economic crisis greater than the 2008 recession. This research is done to improve understanding of the concepts and underlying principles of sustainable entrepreneurship, as the entrepreneurial activity is a crucial aspect to be considered in reducing this negative. For the purpose of achieving this objective, a comprehensive literature review is undertaken and outlined the fundamental themes that emerged. It is clear from this study that in order to fully realize the potential of entrepreneurs and MSMEs in the wake of the pandemic, structural policies that increase their resilience and competitiveness are essential.Copyright © 2022 Wolters Kluwer Medknow Publications. All rights reserved.

7.
Pharmaceutical Technology ; 47(1):19-21, 2023.
Article in English | EMBASE | ID: covidwho-2244278
8.
Resources, Conservation and Recycling Advances ; 15 (no pagination), 2022.
Article in English | EMBASE | ID: covidwho-2228887
9.
BioPharm International ; 35(10):10-15, 2022.
Article in English | EMBASE | ID: covidwho-2207457
10.
NeuroQuantology ; 20(20):560-576, 2022.
Article in English | EMBASE | ID: covidwho-2206895

ABSTRACT

All business actors have been compelled to adjust to these changes by the dynamics of the business environment, as well as the advancement of technology and information. In addition, the COVID-19 pandemic epidemic has compelled business people to take a fresh look at how their organizations run. Identify the variables that affect the business performance of SME's Women business actors by examining the impact of adaptive behavior and locus of control on business performance through the use of entrepreneurial orientation as an intervening variable. Research Design, Data, and Methodology: Data collection in this study was carried out by distributing questionnaires to 94 Women Entrepreneurs in South Sulawesi as a respondent. Partial Least Square (PLS) analysis was used as data analysis. Result(s): This study indicates that adaptive behavior has not directly effect on SMES performance but it will be significant effect if mediated by entrepreneurship orientation, locus of control has a significant effect to SME's Performance both directly or indirectly by mediation of entrepreneurship orientation. Entrepreneurship orientation has a positive and significant effect on SME's Performance, Conclusion(s): SME's Performance will be influenced by various factors including the influence of individual factors such as adaptive behavior and locus of control. These two factors affect the entrepreneurial orientation and have consequences for improving performance. Copyright © 2022, Anka Publishers. All rights reserved.

11.
NeuroQuantology ; 20(16):3569-3577, 2022.
Article in English | EMBASE | ID: covidwho-2206874

ABSTRACT

Thepaperexaminestheinfluenceofvariousfactorsontheworldwideeconomywhileconductingbusinessactiviti es.Newmanagementpracticeshaveevolvedinthelastdecade,includingunprecedentedeventslikeCOVID-19pandemic.Globalizationofhumanityhasbecomeaquestionofthecontemporarytime.Mentalpollution,whic hisspreadingoutwildly,mustbepaidattentiontoo.Paceofcertaineconomicactivitiescanbeseeninadwindlingsit uation.Theresearchindicatesavividrelationshipamongmultiplefactorsindifferentorganisationalstructuresfor carryingoutrequiredbusinessactivities.Worldhaswitnessedatransformeddimensionofhumanityalongwithliv elihoodactivities.Foreignpolicyisnolongerunaffectedbythesehappenings. Copyright © 2022, Anka Publishers. All rights reserved.

12.
Drug Topics ; 166(8):20-22, 2022.
Article in English | EMBASE | ID: covidwho-2170230
13.
Osteopathic Family Physician ; 13(3):8-9, 2021.
Article in English | EMBASE | ID: covidwho-2167754
15.
Journal of Commercial Biotechnology ; 26(3):21-24, 2021.
Article in English | EMBASE | ID: covidwho-2144881
16.
Pharmaceutical Journal ; 308(7959), 2022.
Article in English | EMBASE | ID: covidwho-2065027
17.
Pharmaceutical Journal ; 307(7956), 2022.
Article in English | EMBASE | ID: covidwho-2065010
18.
Pharmaceutical Journal ; 306(7947), 2022.
Article in English | EMBASE | ID: covidwho-2064928
19.
Pharmaceutical Journal ; 308(7957), 2022.
Article in English | EMBASE | ID: covidwho-2043165
20.
Advances in Ophthalmology and Optometry ; 7(1):I-IV, 2022.
Article in English | EMBASE | ID: covidwho-2008187
SELECTION OF CITATIONS
SEARCH DETAIL